2nd TCR-based Therapies Summit
June 8 - 10, 2021 - MA USHanson Wade
info@hansonwade.com
Phone:+1 617 455 4188
Running digitally for 2021, the 2nd TCR-based Therapies Summit is the leading industry-focused meeting dedicated to supercharging the expanded TCR repertoire through enhanced target specificity, density and binding affinity for solid tumor indications. This June (8-10), join this exclusive community online to virtually network and learn from the leading experts in pharma, biotech and academia, as we discuss how to how to overcome on-target off-tumor toxicity, enhance the binding affinity and avidity of TCR-T therapies and utilize dual targeting and combination approaches for enhanced efficacy. Navigate across 3 days packed with dedicated, interactive formats exploring the identification of novel targets, the importance of safety profiling, and discuss optimization of soluble approaches for the development of next-generation TCR-T products.